通用GPU厂商天数智芯启动招股:发行价144.6港元,1月8日挂牌交易

Core Viewpoint - TianShu ZhiXin, the first general-purpose GPU manufacturer in China, has officially launched its IPO process, aiming to raise approximately HKD 3.68 billion through the issuance of 25.43 million shares at a price of HKD 144.6 per share [2] Group 1: IPO Details - The IPO subscription period is from December 30 to January 5, with 10% of the shares allocated for public offering in Hong Kong and the remainder for international placement [2] - The company has formed a cornerstone investor team consisting of 18 top investment firms, with a total subscription amount of HKD 1.583 billion [2] Group 2: Product Development - TianShu ZhiXin has successfully launched two product series, "TianGai" and "ZhiKai," establishing a complete general-purpose computing power system that meets diverse computing needs from AI model training to edge inference [3] - The "TianGai Gen1," released in 2021, is China's first mass-produced general-purpose GPU product, utilizing a 7nm process, and has achieved mass production and commercialization [3] - The "TianGai Gen2" has successfully entered mass production in Q4 2023, while the "TianGai Gen3" is expected to be released in Q3 2024 and enter mass production in Q1 2026 [3] Group 3: Market Performance - The number of customers has increased from 22 in 2022 to 181 in 2024, indicating a significant growth trajectory [5] - The company has served over 290 clients across various sectors, including cloud computing, AI model development, and healthcare, with more than 900 actual deployments in key industries [5] - GPU shipments have doubled from 7,800 units in 2022 to 16,800 units in 2024, reflecting strong market recognition of product performance and stability [6] Group 4: Financial Overview - Revenue has shown a significant upward trend, with figures of CNY 189 million, CNY 289 million, and CNY 540 million for 2022, 2023, and 2024 respectively, representing a compound annual growth rate of 68.8% [6] - Despite revenue growth, the company remains in a loss position, with net losses increasing from CNY 553.6 million in 2022 to CNY 817 million in 2023, and projected to reach CNY 892 million in 2024 [7] - The primary reasons for the losses include increased R&D costs, administrative expenses, and sales expenses, with expectations of further increases in net losses due to rising salary expenditures and ongoing product development investments [7] Group 5: Strategic Focus - The company plans to use the funds raised from the IPO to focus on R&D, sales, and marketing, aiming to accelerate technology iteration and commercialization processes [7]